ERS Webinar

View all ERS Webinar

ERS guideline on withdrawal of inhaled corticosteroids in COPD

Chairs: Marc Miravitlles (Barcelona, Spain); Speaker: James Chalmers (Dundee, United Kingdom)

There is frequent inappropriate use of inhaled corticosteroids (ICS) in COPD. ICS are useful in prevention of exacerbations, but an increasing number of patients with mild COPD and infrequent exacerbations are being treated with ICS. The long-term use of ICS is associated with increases risk of side effects, such as pneumonia; therefore, strategies for safe ICS withdrawal are important in clinical practice.

Educational aims

Participants will be able to:

  • Identify patients in which ICS can be safely discontinued.
  • Conversely, identify which patients should not be discontinued from ICS due to an increased risk of exacerbation due to discontinuation.
  • Gain some insight into how to discontinue ICS in COPD.


Lecture with case presentation


  • Indication of ICS in COPD
  • Risk of side effects associated to long-term use of ICS
  • Criteria for ICS discontinuation
  • How to withdraw ICS in COPD

Learning outcomes

Following this course, participants will be able to:

  1. Describe the side effects associated with long-term use of ICS in COPD.
  2. Outline the indications of ICS in COPD
  3. Identify patients in which ICS should be discontinued
  4. Identify patients in which ICS should not be discontinued

Target audience

Clinicians, trainees, guidelines developers

CME credit

This webinar is accredited by the European Board for Accreditation in Pneumology (EBAP), 1 CME credit per 1-hour attendance. The CME credit will be granted upon attendance during the LIVE webinar only (attendance of at least 60 minutes is required).

What is a webinar?

The webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting.

This webinar comprises of a 40-minute lecture followed by a 20-minute question-and-answer sessions. During the webinar you will be asked to share your opinion on issues related to the topic using interactive polls.

All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.

Login guidelines

More information will be communicated in due course.

  • Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact
  • Check Central European Summer Time.
  • To achieve the best quality, we recommend to stop all other programmes and to avoid downloading anything from the internet during your connection to the lecture.
  • Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.

Target Audience

  • Adult Pulmonologist/Clinician
  • Clinical Researcher
  • General Practitioner
  • Medical Student
  • Nurse
  • Other
  • Patient
  • Physician in Pulmonary Training
  • Scientist (basic, translational)

Diseases / Methods

Airway diseases
Cell and molecular biology
General respiratory patient care
Public health
Pulmonary function testing